[DPHARMA] QoQ Cumulative Quarter Result on 31-Mar-2014 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
20-May-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Mar-2014 [#1]
Profit Trend
QoQ- -74.08%
YoY- 24.87%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Revenue 176,961 125,937 81,118 40,495 162,405 116,671 75,826 75.67%
PBT 46,509 32,589 21,302 11,175 40,175 31,017 21,963 64.67%
Tax 0 -8,014 -5,410 -2,810 -7,900 -6,842 -4,575 -
NP 46,509 24,575 15,892 8,365 32,275 24,175 17,388 92.34%
-
NP to SH 35,271 24,575 15,892 8,365 32,275 24,175 17,388 60.03%
-
Tax Rate 0.00% 24.59% 25.40% 25.15% 19.66% 22.06% 20.83% -
Total Cost 130,452 101,362 65,226 32,130 130,130 92,496 58,438 70.55%
-
Net Worth 192,942 187,436 179,045 190,050 181,850 179,125 187,340 1.97%
Dividend
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Div 25,679 5,553 5,551 - 24,293 - 5,550 176.89%
Div Payout % 72.81% 22.60% 34.93% - 75.27% - 31.92% -
Equity
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Net Worth 192,942 187,436 179,045 190,050 181,850 179,125 187,340 1.97%
NOSH 138,807 138,841 138,794 138,723 138,817 138,856 138,770 0.01%
Ratio Analysis
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
NP Margin 26.28% 19.51% 19.59% 20.66% 19.87% 20.72% 22.93% -
ROE 18.28% 13.11% 8.88% 4.40% 17.75% 13.50% 9.28% -
Per Share
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
RPS 127.49 90.71 58.44 29.19 116.99 84.02 54.64 75.64%
EPS 25.41 17.70 11.45 6.03 23.25 17.41 12.53 60.00%
DPS 18.50 4.00 4.00 0.00 17.50 0.00 4.00 176.81%
NAPS 1.39 1.35 1.29 1.37 1.31 1.29 1.35 1.96%
Adjusted Per Share Value based on latest NOSH - 138,723
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
RPS 18.40 13.09 8.43 4.21 16.88 12.13 7.88 75.73%
EPS 3.67 2.55 1.65 0.87 3.36 2.51 1.81 59.99%
DPS 2.67 0.58 0.58 0.00 2.53 0.00 0.58 175.96%
NAPS 0.2006 0.1949 0.1861 0.1976 0.189 0.1862 0.1948 1.96%
Price Multiplier on Financial Quarter End Date
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Date 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 -
Price 2.50 3.17 2.97 3.03 2.58 2.55 2.38 -
P/RPS 1.96 3.49 5.08 10.38 2.21 3.03 4.36 -41.23%
P/EPS 9.84 17.91 25.94 50.25 11.10 14.65 18.99 -35.40%
EY 10.16 5.58 3.86 1.99 9.01 6.83 5.26 54.91%
DY 7.40 1.26 1.35 0.00 6.78 0.00 1.68 167.98%
P/NAPS 1.80 2.35 2.30 2.21 1.97 1.98 1.76 1.50%
Price Multiplier on Announcement Date
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Date 24/02/15 21/11/14 26/08/14 20/05/14 26/02/14 19/11/13 28/08/13 -
Price 2.92 3.01 3.37 3.09 2.60 2.56 2.44 -
P/RPS 2.29 3.32 5.77 10.59 2.22 3.05 4.47 -35.89%
P/EPS 11.49 17.01 29.43 51.24 11.18 14.70 19.47 -29.57%
EY 8.70 5.88 3.40 1.95 8.94 6.80 5.14 41.89%
DY 6.34 1.33 1.19 0.00 6.73 0.00 1.64 145.71%
P/NAPS 2.10 2.23 2.61 2.26 1.98 1.98 1.81 10.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment